申请人:SCHLAPBACH Achim
公开号:US20120022030A1
公开(公告)日:2012-01-26
The present invention describes tetracyclic compounds of formula (IA) or (IB),
wherein the symbols R, X, A, Y, R2, R3 and D are as defined in the specification, their use in the treatment of certain diseases, e.g. depending on MK-2 or TNF activity, and ways of manufacturing them.
本发明描述了公式(IA)或(IB)的四环化合物,其中符号R、X、A、Y、R2、R3和D如规范中所定义,它们的用途在于治疗某些疾病,例如取决于MK-2或TNF活性,并且描述了它们的制造方法。